Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50573) 50573
Book Review (9919) 9919
Newsletter (3244) 3244
Publication (2259) 2259
Magazine Article (384) 384
Newspaper Article (325) 325
Conference Proceeding (249) 249
Book Chapter (178) 178
Book / eBook (64) 64
Trade Publication Article (64) 64
Dissertation (35) 35
Transcript (31) 31
Reference (23) 23
Web Resource (11) 11
Paper (9) 9
Government Document (3) 3
Archival Material (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (41453) 41453
humans (38320) 38320
antihypertensive agents - therapeutic use (27705) 27705
male (24412) 24412
hypertension - drug therapy (22482) 22482
female (21292) 21292
hypertension (20897) 20897
middle aged (17348) 17348
aged (14052) 14052
adult (11619) 11619
blood pressure - drug effects (11191) 11191
antihypertensive drugs (9603) 9603
blood pressure (8990) 8990
hypertension - physiopathology (8622) 8622
treatment outcome (8165) 8165
peripheral vascular disease (7855) 7855
animals (7670) 7670
antihypertensive agents - pharmacology (7653) 7653
antihypertensive agents - administration & dosage (7332) 7332
risk factors (7301) 7301
pharmacology & pharmacy (6197) 6197
blood-pressure (6016) 6016
antihypertensive agents - adverse effects (5734) 5734
hypertension - complications (5416) 5416
abridged index medicus (5276) 5276
rats (4941) 4941
drug therapy (4940) 4940
drug therapy, combination (4840) 4840
cardiac & cardiovascular systems (4653) 4653
medicine, general & internal (4394) 4394
research (4157) 4157
care and treatment (4030) 4030
aged, 80 and over (3836) 3836
angiotensin-converting enzyme inhibitors - therapeutic use (3562) 3562
mortality (3504) 3504
time factors (3483) 3483
double-blind method (3125) 3125
prospective studies (2965) 2965
hypertension - diagnosis (2955) 2955
prevalence (2889) 2889
hypertension - epidemiology (2886) 2886
follow-up studies (2808) 2808
risk (2800) 2800
analysis (2646) 2646
antihypertensive treatment (2628) 2628
medicine & public health (2607) 2607
antihypertensive agents (2595) 2595
prevention (2505) 2505
health aspects (2482) 2482
therapy (2475) 2475
management (2448) 2448
calcium channel blockers - therapeutic use (2433) 2433
blood pressure - physiology (2430) 2430
dose-response relationship, drug (2319) 2319
retrospective studies (2264) 2264
disease (2262) 2262
ophthalmology (2213) 2213
diabetes (2193) 2193
adolescent (2184) 2184
diuretics (2128) 2128
hypertension - therapy (2050) 2050
adrenergic beta-antagonists - therapeutic use (2036) 2036
antihypertensive therapy (2011) 2011
angiotensin (2008) 2008
medical research (1987) 1987
internal medicine (1962) 1962
drugs (1959) 1959
heart rate - drug effects (1953) 1953
stroke (1950) 1950
clinical trials as topic (1889) 1889
randomized controlled trials as topic (1830) 1830
diuretics - therapeutic use (1829) 1829
dosage and administration (1808) 1808
urology & nephrology (1782) 1782
hypertension - etiology (1740) 1740
cardiovascular disease (1725) 1725
cardiology (1700) 1700
patient compliance (1647) 1647
prognosis (1638) 1638
trial (1638) 1638
cardiovascular diseases - prevention & control (1623) 1623
medicine, experimental (1587) 1587
rats, inbred shr (1563) 1563
hypertension, pulmonary - drug therapy (1557) 1557
double-blind (1514) 1514
age factors (1500) 1500
cardiovascular diseases (1496) 1496
glaucoma (1496) 1496
tetrazoles - therapeutic use (1465) 1465
clinical trials (1456) 1456
intraocular pressure - drug effects (1456) 1456
reports (1424) 1424
cross-sectional studies (1414) 1414
diagnosis (1408) 1408
blood pressure monitoring, ambulatory (1380) 1380
hypertension - blood (1372) 1372
drug combinations (1369) 1369
losartan (1355) 1355
practice guidelines as topic (1346) 1346
risk assessment (1344) 1344
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49184) 49184
German (1220) 1220
Russian (1003) 1003
French (944) 944
Spanish (588) 588
Japanese (328) 328
Italian (270) 270
Polish (220) 220
Chinese (179) 179
Portuguese (136) 136
Czech (116) 116
Hungarian (91) 91
Danish (89) 89
Dutch (80) 80
Romanian (80) 80
Norwegian (69) 69
Swedish (66) 66
Hebrew (32) 32
Ukrainian (32) 32
Turkish (30) 30
Croatian (29) 29
Bulgarian (20) 20
Serbian (18) 18
Finnish (17) 17
Slovak (17) 17
Korean (15) 15
Lithuanian (8) 8
Bosnian (2) 2
Icelandic (2) 2
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
by Galie, N and Humbert, M and Vachiery, JL and Gibbs, S and Lang, I and Torbicki, A and Simonneau, G and Peacock, A and Noordegraaf, AV and Beghetti, M and Ghofrani, A and Sanchez, MAG and Hansmann, G and Klepetko, W and Lancellotti, P and Matucci, M and McDonagh, T and Pierard, LA and Trindade, PT and Zompatori, M and Hoeper, M and European Respiratory Soc ERS and European Soc Cardiology ESC and ESC Scientific Document Group
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 01/2016, Volume 37, Issue 1, pp. 67 - 67
Document Reviewers: Victor Aboyans (CPG Review Coordinator) (France), Antonio Vaz Carneiro (CPG Review Coordinator) (Portugal), Stephan Achenbach (Germany),... 
Heart failure | Connective tissue disease | Lung disease | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | Left heart disease | LONG-TERM SURVIVAL | Endothelin receptor antagonists | Congenital heart disease | PRESERVED EJECTION FRACTION | RANDOMIZED CONTROLLED-TRIAL | Chronic thromboembolic | CALCIUM-CHANNEL BLOCKERS | Pulmonary hypertension | Phosphodiesterase type 5 inhibitors | Guidelines | RIGHT-VENTRICULAR DYSFUNCTION | Respiratory failure | Prostacyclin analogues | ENDOTHELIN-RECEPTOR ANTAGONIST | Pulmonary arterial hypertension | PLACEBO-CONTROLLED TRIAL | EXTRACORPOREAL MEMBRANE-OXYGENATION | SEVERE PORTOPULMONARY HYPERTENSION | Risk Assessment - methods | Hypertension, Pulmonary - diagnosis | Hypertension, Portal - complications | Humans | Echocardiography - methods | Tomography, X-Ray Computed - methods | Genetic Counseling | Hypertension, Pulmonary - therapy | Hypertension, Portal - diagnosis | Drug Interactions | Cardiac Catheterization - methods | Electrocardiography | Magnetic Resonance Angiography - methods | Elective Surgical Procedures - methods | Child | Biomarkers - metabolism | Exercise Therapy - methods | Cross Infection - prevention & control | Risk Factors | Social Support | Connective Tissue Diseases - therapy | Antihypertensive Agents - therapeutic use | Hemangioma - diagnosis | Hemangioma - complications | Heart Defects, Congenital - complications | Hypertension, Portal - therapy | HIV Infections - complications | Heart Defects, Congenital - diagnosis | Travel Medicine - methods | Health Status | Hypertension, Pulmonary - etiology | Hemoptysis - etiology | Genetic Testing - methods | Thromboembolism - diagnosis | Hemangioma - therapy | Balloon Embolectomy - methods | Exercise Test - methods | HIV Infections - diagnosis | Multimodal Imaging - methods | Adult | Female | Terminal Care - methods | Pregnancy Complications, Cardiovascular - therapy | Ventricular Dysfunction, Right - therapy | Therapies, Investigational - methods | Respiratory Function Tests - methods | Connective Tissue Diseases - diagnosis | Treatment Outcome | Arrhythmias, Cardiac - etiology | Thromboembolism - therapy | Pregnancy | Algorithms | Thromboembolism - complications | HIV Infections - therapy | Ventricular Dysfunction, Right - complications | Combined Modality Therapy - methods | Heart Defects, Congenital - therapy | Lung Transplantation - methods | Referral and Consultation | Patient Compliance | Connective Tissue Diseases - complications | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
by Warwick, Jane and Warwick, Jane and Falaschetti, Emanuela and Falaschetti, Emanuela and Rockwood, Kenneth and Rockwood, Kenneth and Mitnitski, Arnold and Mitnitski, Arnold and Thijs, Lutgarde and Thijs, Lutgarde and Beckett, Nigel and Beckett, Nigel and Bulpitt, Christopher and Bulpitt, Christopher and Peters, Ruth and Peters, Ruth
BMC Medicine, ISSN 1741-7015, 04/2015, Volume 13, Issue 1, pp. 1 - 8
Background: Treatment for hypertension with antihypertensive medication has been shown to reduce stroke, cardiovascular events, and mortality in older adults,... 
Hypertension | Frailty | Antihypertensives | Ageing | MORTALITY | MEDICINE, GENERAL & INTERNAL | OLDEST-OLD | TRANSITIONS | BENEFITS | Double-Blind Method | Comorbidity | Humans | Indapamide - therapeutic use | Hypertension - drug therapy | Male | Frail Elderly | Antihypertensive Agents - therapeutic use | Incidence | Aged, 80 and over | Quality of Life | Female | Stroke - epidemiology | Blood Pressure - drug effects | Hypertension - epidemiology | Drug Therapy, Combination | Perindopril - therapeutic use | Antihypertensive drugs | Care and treatment | Research | Analysis | Investigations | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
by McMurray, JJV and Adamopoulos, S and Anker, SD and Auricchio, A and Bohm, M and Dickstein, K and Falk, V and Filippatos, G and Fonseca, C and Gomez-Sanchez, MA and Jaarsma, T and Kober, L and Lip, GYH and Maggioni, AP and Parkhomenko, A and Pieske, BM and Popescu, BA and Ronnevik, PK and Rutten, FH and Schwitter, J and Seferovic, P and Stepinska, J and Trindade, PT and Voors, AA and Zannad, F and Zeiher, A and Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology and ESC Committee for Practice Guidelines and Hälsa, Aktivitet, Vård (HAV) and Linköpings universitet and Institutionen för samhälls- och välfärdsstudier and Hälsouniversitetet
EUROPEAN JOURNAL OF HEART FAILURE, ISSN 1388-9842, 08/2012, Volume 14, Issue 8, pp. 803 - 869
ESC Committee for Practice Guidelines (CPG): Jeroen J. Bax (CPG Chairperson) (The Netherlands), Helmut Baumgartner (Germany), Claudio Ceconi (Italy), Veronica... 
Heart failure | NATRIURETIC PEPTIDE LEVELS | CARDIAC & CARDIOVASCULAR SYSTEMS | Digitalis | MECHANICAL CIRCULATORY SUPPORT | Transplantation | CARDIAC-RESYNCHRONIZATION THERAPY | Beta-blockers | CONVERTING-ENZYME-INHIBITORS | OBSTRUCTIVE PULMONARY-DISEASE | LEFT-VENTRICULAR DYSFUNCTION | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | EXPERT CONSENSUS STATEMENT | Reninangiotensin system | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | Natriuretic peptides | Ejection fraction | Cardiotonic Agents - therapeutic use | Stroke Volume | Natriuretic Peptides | Algorithms | Societies, Medical | Renin-Angiotensin System | Ventricular Function, Left | Europe | Humans | Heart Failure - diagnosis | Antihypertensive Agents - therapeutic use | Heart Failure - drug therapy | Index Medicus | Renin–angiotensin system | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma—study protocol
by King, Anthony J and Fernie, Gordon and Azuara-Blanco, Augusto and Burr, Jennifer M and Garway-Heath, Ted and Sparrow, John M and Vale, Luke and Hudson, Jemma and MacLennan, Graeme and McDonald, Alison and Barton, Keith and Norrie, John
British Journal of Ophthalmology, ISSN 0007-1161, 07/2018, Volume 102, Issue 7, pp. 922 - 928
BackgroundPresentation with advanced glaucoma is the major risk factor for lifetime blindness. Effective intervention at diagnosis is expected to minimise risk... 
clinical trial | treatment surgery | intraocular pressure | glaucoma | treatment medical | MANAGEMENT | VISION | RISK | INTRAOCULAR-PRESSURE | VISUAL-FIELD LOSS | OPEN-ANGLE GLAUCOMA | COLLABORATIVE INITIAL GLAUCOMA | OCULAR HYPERTENSION | OPHTHALMOLOGY | QUALITY-OF-LIFE | PROGRESSION | Quality-Adjusted Life Years | Visual Fields - physiology | Glaucoma, Open-Angle - surgery | Prospective Studies | Sickness Impact Profile | Trabeculectomy - economics | Humans | Middle Aged | Glaucoma, Open-Angle - economics | Glaucoma, Open-Angle - physiopathology | Intraocular Pressure - physiology | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Glaucoma, Open-Angle - drug therapy | Cost-Benefit Analysis | Quality of Life | Female | Aged | Health Status | Research Design | Visual Acuity - physiology | Antihypertensive Agents - economics | Trabeculectomy - methods | Cataracts | Glaucoma | Collaboration | Medical treatment | Questionnaires | Family medical history | Ophthalmology | Eye surgery | Patients | Quality of life | Index Medicus | Clinical Science | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
by Muntner, Paul and Muntner, Paul and Davis, Barry R and Cushman, William C and Bangalore, Sripal and Calhoun, David A and Pressel, Sara L and Black, Henry R and Kostis, John B and Probstfield, Jeffrey L and Whelton, Paul K and Rahman, Mahboob and ALLHAT Collaborative Res Grp and ALLHAT Collaborative Research Group
Hypertension, ISSN 0194-911X, 11/2014, Volume 64, Issue 5, pp. 1012 - 1021
Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled hypertension despite the use of >= 3 antihypertensive medication classes or... 
kidney failure, chronic | Chronic | Kidney failure | diuretics | cardiovascular diseases | antihypertensive | Antihypertensive agents | agents | CONVERTING ENZYME-INHIBITOR | CALCIUM-CHANNEL BLOCKER | UNITED-STATES | SYMPATHETIC DENERVATION | kidney failure | RISK | antihypertensive agents | PREVALENCE | CHLORTHALIDONE | STROKE | PERIPHERAL VASCULAR DISEASE | OUTCOMES | chronic | HIGH BLOOD-PRESSURE | Antihypertensive Agents - pharmacology | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Incidence | Kidney Failure, Chronic - epidemiology | Treatment Failure | Cardiovascular Diseases - epidemiology | Hypertension - complications | Female | Aged | Blood Pressure - drug effects | Blood Pressure - physiology | Hypolipidemic Agents - therapeutic use | Myocardial Infarction - prevention & control | Drug Resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial
by Pepine, Carl J and Handberg, Eileen M and Cooper-DeHoff, Rhonda M and Marks, Ronald G and Kowey, Peter and Messerli, Franz H and Mancia, Giuseppe and Cangiano, José L and Garcia-Barreto, David and Keltai, Matyas and Erdine, Serap and Bristol, Heather A and Kolb, H. Robert and Bakris, George L and Cohen, Jerome D and Parmley, William W and for the INVEST Investigators and INVEST Investigators
JAMA, ISSN 0098-7484, 12/2003, Volume 290, Issue 21, pp. 2805 - 2816
CONTEXT Despite evidence of efficacy of antihypertensive agents in treating hypertensive patients, safety and efficacy of antihypertensive agents for coronary... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | THERAPY | METAANALYSIS | MONOTHERAPY | ANTIHYPERTENSIVE DRUGS | OUTCOMES | CARDIOVASCULAR MORBIDITY | BETA-BLOCKERS | INTERVENTION | BLOOD-PRESSURE | Blood Pressure | Heart Rate | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Treatment Outcome | Coronary Artery Disease - drug therapy | Sodium Chloride Symporter Inhibitors - therapeutic use | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Verapamil - therapeutic use | Atenolol - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Coronary Artery Disease - complications | Diuretics | Hypertension - complications | Female | Indoles - therapeutic use | Aged | Drug Therapy, Combination | Hydrochlorothiazide - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hypertension | Calcium | Coronary vessels | Medical treatment | Mortality | Morbidity | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study. The Impact of Treatment and Other Baseline Factors
by Musch, David C and Gillespie, Brenda W and Lichter, Paul R and Niziol, Leslie M and Janz, Nancy K and CIGTS Study Investigators
Ophthalmology, ISSN 0161-6420, 2009, Volume 116, Issue 2, pp. 200 - e1
Purpose: To evaluate factors associated with visual field (VF) progression, using all available follow-up through 9 years after treatment initiation, in the... 
SURGERY | RISK-FACTORS | THERAPY | OPHTHALMOLOGY | LONG-TERM PROGRESSION | INTRAOCULAR-PRESSURE | ASSOCIATION | TRABECULECTOMY | Trabeculectomy | Glaucoma, Open-Angle - surgery | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Glaucoma, Open-Angle - physiopathology | Intraocular Pressure - physiology | Male | Antihypertensive Agents - therapeutic use | Disease Progression | Glaucoma, Open-Angle - drug therapy | Vision Disorders - physiopathology | Aging - physiology | Visual Fields | Tonometry, Ocular | Adult | Female | Aged | Visual Field Tests | Visual Acuity - physiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Detecting heterogeneous treatment effects to guide personalized blood pressure treatment a modeling study of randomized clinical trials
by Basu, Sanjay and Sussman, Jeremy B and Hayward, Rod A
Annals of Internal Medicine, ISSN 0003-4819, 03/2017, Volume 166, Issue 5, pp. 354 - 360
Two recent randomized trials produced discordant results when testing the benefits and harms of treatment to reduce blood pressure (BP) in patients with... 
Cardiovascular Diseases - complications | Cardiovascular Diseases - prevention & control | Computer Simulation | Humans | Risk Factors | Hypertension - complications | Adult | Hypertension - drug therapy | Research Design - standards | Antihypertensive Agents - therapeutic use | Randomized Controlled Trials as Topic - standards | Clinical trials | Cardiovascular disease | Blood pressure | Veterans | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial
by Han, Benjamin H and Sutin, David and Williamson, Jeff D and Davis, Barry R and Piller, Linda B and Pervin, Hannah and Pressel, Sara L and Blaum, Caroline S and ALLHAT Collaborative Res Grp and ALLHAT Collaborative Research Group and for the ALLHAT Collaborative Research Group
JAMA Internal Medicine, ISSN 2168-6106, 07/2017, Volume 177, Issue 7, pp. 955 - 965
IMPORTANCE: While statin therapy for primary cardiovascular prevention has been associated with reductions in cardiovascular morbidity, the effect on all-cause... 
C-REACTIVE PROTEIN | LIPID-LOWERING TREATMENT | CAUSE MORTALITY | MEDICINE, GENERAL & INTERNAL | ELDERLY INDIVIDUALS | CHOLESTEROL LEVELS | DISEASE | VASCULAR EVENTS | RISK | PEOPLE | ROSUVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Hypertension - drug therapy | Male | Medication Therapy Management | Antihypertensive Agents - therapeutic use | Cholesterol, LDL - analysis | Primary Prevention - statistics & numerical data | Hypercholesterolemia - drug therapy | Outcome and Process Assessment (Health Care) | Pravastatin - administration & dosage | Hypercholesterolemia - diagnosis | Primary Prevention - methods | Cardiovascular Diseases - mortality | Female | Aged | Drug Monitoring | Prevention | Hypertension | Treatment outcome | Care and treatment | Patient outcomes | Aged patients | Dosage and administration | Comparative analysis | Heart attack | Statins | Antilipemic agents | Index Medicus | Abridged Index Medicus | Online First | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Effect of Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning—the DANTE Study Leiden: A Randomized Clinical Trial
by Moonen, Justine E. F and Foster-Dingley, Jessica C and de Ruijter, Wouter and van der Grond, Jeroen and Bertens, Anne Suzanne and van Buchem, Mark A and Gussekloo, Jacobijn and Middelkoop, Huub A and Wermer, Marieke J. H and Westendorp, Rudi G. J and de Craen, Anton J. M and van der Mast, Roos C
JAMA Internal Medicine, ISSN 2168-6106, 10/2015, Volume 175, Issue 10, pp. 1622 - 1630
IMPORTANCE: Observational studies indicate that lower blood pressure (BP) increases risk for cognitive decline in elderly individuals. Older persons are at... 
PRESSURE | MEDICINE, GENERAL & INTERNAL | DEMENTIA | METAANALYSIS | VASCULAR RISK | DISEASE | OLDEST-OLD | CEREBRAL-BLOOD-FLOW | HYPERTENSION | AGE | DECLINE | Outcome Assessment (Health Care) | Humans | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Antihypertensive Agents - classification | Cognition - drug effects | Cognitive Dysfunction - physiopathology | Withholding Treatment | Cognitive Dysfunction - prevention & control | Hypertension - physiopathology | Intelligence Tests | Antihypertensive Agents - adverse effects | Activities of Daily Living | Hypertension - psychology | Cognition - physiology | Quality of Life | Female | Geriatric Assessment - methods | Aged | Blood Pressure - drug effects | Cognitive Dysfunction - diagnosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
by Calhoun, David A and Jones, Daniel and Textor, Stephen and Goff, David C and Murphy, Timothy P and Toto, Robert D and White, Anthony and Cushman, William C and White, William and Sica, Domenic and Ferdinand, Keith and Giles, Thomas D and Falkner, Bonita and Carey, Robert M
Hypertension, ISSN 0194-911X, 06/2008, Volume 51, Issue 6, pp. 1403 - 1419
Resistant hypertension is a common clinical problem faced by both primary care clinicians and specialists. While the exact prevalence of resistant hypertension... 
blood pressure | OBSTRUCTIVE SLEEP-APNEA | REFRACTORY HYPERTENSION | EPITHELIAL SODIUM-CHANNEL | SECONDARY HYPERTENSION | PRIMARY ALDOSTERONISM | AHA Scientific Statements | CONVERTING-ENZYME-INHIBITOR | PERIPHERAL VASCULAR DISEASE | POSITIVE AIRWAY PRESSURE | ANTIHYPERTENSIVE THERAPY | PROGNOSTIC-SIGNIFICANCE | hypertension | RENAL-ARTERY STENOSIS | Sleep Apnea, Obstructive - therapy | Antihypertensive Agents - pharmacology | Life Style | Pharmacogenetics | Prognosis | Humans | Sleep Apnea, Obstructive - complications | Antihypertensive Agents - therapeutic use | Hypertension - etiology | Renal Artery Obstruction - complications | Diet | Weight Loss | Hypertension - epidemiology | Hypertension - genetics | Hypertension - therapy | Patient Compliance | Hypertension - diagnosis | Renal Artery Obstruction - therapy | Blood Pressure Determination | Drug Resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
by Calhoun, David A and Jones, Daniel and Textor, Stephen and Goff, David C and Murphy, Timothy P and Toto, Robert D and White, Anthony and Cushman, William C and White, William and Sica, Domenic and Ferdinand, Keith and Giles, Thomas D and Falkner, Bonita and Carey, Robert M and American Heart Association Professional Education Committee, Heart Association Professional Education Committee and American Heart Association Professional Education Committee
Circulation, ISSN 0009-7322, 06/2008, Volume 117, Issue 25, pp. e510 - 526
Resistant hypertension is a common clinical problem faced by both primary care clinicians and specialists. While the exact prevalence of resistant hypertension... 
blood pressure | OBSTRUCTIVE SLEEP-APNEA | CARDIAC & CARDIOVASCULAR SYSTEMS | REFRACTORY HYPERTENSION | EPITHELIAL SODIUM-CHANNEL | SECONDARY HYPERTENSION | PRIMARY ALDOSTERONISM | AHA Scientific Statements | CONVERTING-ENZYME-INHIBITOR | PERIPHERAL VASCULAR DISEASE |